Related Experiment Video
Updated: Jul 2, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
Andrew D Marques1, Jevon Graham-Wooten2, Ayannah S Fitzgerald2
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Long-term SARS-CoV-2 infection in immunocompromised patients accelerates viral evolution, leading to increased mutations and the emergence of antibody-resistant variants. This study tracked viral changes in five patients over extended periods.
Area of Science:
- Virology
- Immunology
- Genomics
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants pose a significant threat to global health.
- Immunocompromised individuals may experience prolonged SARS-CoV-2 infections, creating environments for viral evolution.
- Understanding viral evolution pathways is crucial for developing effective treatments and control strategies.
Purpose of the Study:
- To investigate the evolutionary pathways of SARS-CoV-2 in immunocompromised patients with prolonged infections.
- To characterize the accumulation of mutations and identify specific variants that emerge during long-term viral persistence.
- To assess the impact of host immune status and therapeutic interventions on viral evolution.
Main Methods:
- Analysis of viral genome sequences from five immunocompromised patients with prolonged SARS-CoV-2 infection (79-203 days).
- Generation of at least two independent viral genome sequences per timepoint to ensure accuracy and assess heterogeneity.
- Monitoring of mutation rates and identification of specific substitutions in the viral genome, particularly in the spike protein.
Main Results:
- Prolonged SARS-CoV-2 infection in immunocompromised patients led to higher rates of viral genome substitution accumulation compared to community background.
- The spike protein coding region showed a significantly higher density of unique mutations.
- Emergence of SARS-CoV-2 variants with substitutions conferring resistance to monoclonal antibodies (bebtelovimab and sotrovimab) was observed.
- No remdesivir-resistant substitutions were detected despite patient treatment.
Conclusions:
- Long-term SARS-CoV-2 infection in immunocompromised individuals is a significant driver of viral evolution and variant generation.
- The spike protein is a key target for viral adaptation, leading to immune escape mechanisms.
- Monitoring viral evolution in persistent infections is essential for understanding pandemic dynamics and guiding therapeutic strategies.
More Related Videos
Related Concept Videos
Stages of Infection
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Viral Mutations
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

